Recombinant Acinetobacter baumannii protein vaccine (Olymvax Biopharmaceuticals)

重组鲍曼不动杆菌蛋白疫苗（成都欧林生物科技）

Report date: 2025/11/06 17:01:29

Base Information

Drug NameRecombinant Acinetobacter baumannii protein vaccine (Olymvax Biopharmaceuticals)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsAcinetobacter Baumannii Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChengdu Oulin Biological Science & Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Oulin Biological Science & Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsAcinetobacter Baumannii Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A